Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites-Reference-Cited by-同舟云学术

Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites

Published:2021-08-25 Issue:10 Volume:19 Page:2554-2558
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Abbattista Maria¹^ORCID,Martinelli Ida¹^ORCID,Peyvandi Flora¹²^ORCID

Affiliation:

1. Fondazione IRCCS Ca’ Granda–Ospedale Maggiore PoliclinicoUOC Medicina GeneraleA. Bianchi Bonomi Hemophilia and Thrombosis Center Milan Italy

2. Università degli Studi di Milano, Department of Pathophysiology and Transplantation Milan Italy

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15493

Reference9 articles.

1. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure

2. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

3. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021

4. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

5. AstraZeneca’s COVID‐19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets.https://www.ema.europa.eu/en/news/astrazenecas‐covid‐19‐vaccine‐ema‐finds‐possible‐link‐very‐rare‐cases‐unusual‐blood‐clots‐low‐blood.Accessed May 2021.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coagulation and inflammatory response after intramuscular or intradermal mRNA-1273 SARS-CoV-2 vaccine: secondary analysis of a randomized trial;Research and Practice in Thrombosis and Haemostasis;2024-03

2. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia: A comprehensive review, release 1 (epidemiologic perspective);Life Cycle;2023-10-29

3. Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination;Biomedicines;2023-10-17

4. Neurological adverse effects after SARS-CoV-2 vaccinations: Etiology should be warranted;NeuroPharmac Journal;2023-08-30

5. Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand;Drug Safety;2023-08-09